Home » Topics » BioWorld Science

BioWorld Science
RSS

Novartis divulges NLRP3 inhibitors

May 18, 2020

FronThera US Pharmaceuticals synthesizes new TYK2 inhibitors

May 18, 2020

Intra-Cellular Therapies patents PDE2A inhibitors

May 18, 2020

Gilead Sciences divulges PD-1/PD-L1 interaction inhibitors

May 18, 2020

Medshine Discovery discloses Wee1 inhibitors

May 18, 2020

TNFAIP2 identified as potential therapeutic target in platinum-resistant urothelial carcinoma

May 18, 2020

Designer proteins for RSV vaccine

May 18, 2020

Microbiome modulates effects of ALS mutation

May 18, 2020

Interim phase II data for apalutamide plus abiraterone acetate/prednisone in prostate cancer

May 18, 2020

First-in-human data for novel proliposomal paclitaxel, TSD-001, in NMIBC

May 18, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...